Global Normal Saline for Parenteral Use Market Growth 2023-2029

Global Normal Saline for Parenteral Use Market Growth 2023-2029

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection
LPI (LP Information)' newest research report, the “Normal Saline for Parenteral Use Industry Forecast” looks at past sales and reviews total world Normal Saline for Parenteral Use sales in 2022, providing a comprehensive analysis by region and market sector of projected Normal Saline for Parenteral Use sales for 2023 through 2029. With Normal Saline for Parenteral Use sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Normal Saline for Parenteral Use industry.
This Insight Report provides a comprehensive analysis of the global Normal Saline for Parenteral Use landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Normal Saline for Parenteral Use portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Normal Saline for Parenteral Use market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Normal Saline for Parenteral Use and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Normal Saline for Parenteral Use.
The global Normal Saline for Parenteral Use market size is projected to grow from US$ 3066.9 million in 2022 to US$ 3854.6 million in 2029; it is expected to grow at a CAGR of 3854.6 from 2023 to 2029.
At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world's largest companies by sales.
This report presents a comprehensive overview, market shares, and growth opportunities of Normal Saline for Parenteral Use market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Flexible Bag
Plastic Bottles
Glass Bottles
Segmentation by application
Intramuscular Injection
Intravenous Injection
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International

Key Questions Addressed in this Report
What is the 10-year outlook for the global Normal Saline for Parenteral Use market?
What factors are driving Normal Saline for Parenteral Use market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Normal Saline for Parenteral Use market opportunities vary by end market size?
How does Normal Saline for Parenteral Use break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.